DE69808938D1 - Verfahren zur herstellung von pharmazeutischen zusammensetzungen - Google Patents
Verfahren zur herstellung von pharmazeutischen zusammensetzungenInfo
- Publication number
- DE69808938D1 DE69808938D1 DE69808938T DE69808938T DE69808938D1 DE 69808938 D1 DE69808938 D1 DE 69808938D1 DE 69808938 T DE69808938 T DE 69808938T DE 69808938 T DE69808938 T DE 69808938T DE 69808938 D1 DE69808938 D1 DE 69808938D1
- Authority
- DE
- Germany
- Prior art keywords
- formulation
- pharmacologically
- acceptable
- pharmaceutical compositions
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9718568.0A GB9718568D0 (en) | 1997-09-03 | 1997-09-03 | Compositions |
PCT/GB1998/002637 WO1999011239A1 (en) | 1997-09-03 | 1998-09-02 | Method for preparing pharmaceutical formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69808938D1 true DE69808938D1 (de) | 2002-11-28 |
DE69808938T2 DE69808938T2 (de) | 2003-07-03 |
Family
ID=10818388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69808938T Expired - Fee Related DE69808938T2 (de) | 1997-09-03 | 1998-09-02 | Verfahren zur herstellung von pharmazeutischen zusammensetzungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US6379692B1 (de) |
EP (1) | EP1009380B1 (de) |
JP (1) | JPH11228386A (de) |
AT (1) | ATE226428T1 (de) |
AU (1) | AU741609B2 (de) |
CA (1) | CA2301325A1 (de) |
DE (1) | DE69808938T2 (de) |
DK (1) | DK1009380T3 (de) |
ES (1) | ES2186207T3 (de) |
GB (2) | GB9718568D0 (de) |
WO (1) | WO1999011239A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001278779A1 (en) * | 2000-08-25 | 2002-03-04 | Senju Pharmaceutical Co. Ltd. | Aqueous suspension preparations |
AU2001290328A1 (en) * | 2000-09-29 | 2002-04-08 | Wakamoto Pharmaceutical Co., Ltd. | Eye drops comprising acyclovir suspension |
US7101576B2 (en) | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
US20040105889A1 (en) * | 2002-12-03 | 2004-06-03 | Elan Pharma International Limited | Low viscosity liquid dosage forms |
BR0309340A (pt) * | 2002-04-19 | 2005-03-08 | Novartis Ag | Materiais, sua preparação e uso |
JP4512700B2 (ja) * | 2003-06-02 | 2010-07-28 | トーアエイヨー株式会社 | アシクロビル含有水溶液製剤 |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
CA2839898C (en) * | 2003-06-13 | 2017-01-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
CA2562190C (en) * | 2004-04-05 | 2012-08-21 | Laboratorios Liomont, S.A. De C.V. | Novel antiviral pharmaceutical composition |
EP1796635A2 (de) * | 2004-09-14 | 2007-06-20 | Molecular Therapeutics, Inc. | D-methionin-formulierung mit verbesserten biopharmazeutischen eigenschaften |
US9775802B2 (en) | 2009-03-24 | 2017-10-03 | Bausch & Lomb Incorporated | Method for preparing suspensions of low-solubility materials |
US20100247666A1 (en) * | 2009-03-24 | 2010-09-30 | Macleod Steven K | Method for Preparing Suspensions of Low-Solubility Materials |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2080106B (en) | 1980-07-18 | 1984-03-07 | Weelcome Foundation Ltd | Acyclovin preparations |
IE51421B1 (en) | 1980-08-01 | 1986-12-24 | Smith & Nephew Ass | Ophthalmic compositions containing triamterene |
GB2217595B (en) * | 1988-04-21 | 1991-11-20 | American Cyanamid Co | Antiinflammatory gel |
GB8919172D0 (en) * | 1989-08-23 | 1989-10-04 | Univ Nottingham | Useful composition |
US5252318A (en) | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
FR2678832B1 (fr) | 1991-07-10 | 1995-03-17 | Europhta Sa Laboratoire | Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation. |
FR2679135B1 (fr) | 1991-07-18 | 1995-05-19 | Europhta Sa Laboratoire | Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation. |
WO1993017664A1 (en) | 1992-03-02 | 1993-09-16 | Alcon Laboratories, Inc. | Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions |
SE9401108D0 (sv) | 1994-03-31 | 1994-03-31 | Leiras Oy | Ophthalmic composition I |
DE4440337A1 (de) | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
JPH08268892A (ja) * | 1995-03-30 | 1996-10-15 | Yuuwa Shoji:Kk | 水溶液製剤及びその製造方法 |
GB2306885B (en) * | 1995-11-08 | 1999-07-14 | Reckitt & Colmann Prod Ltd | Supersaturated Pharmaceutical Compositions |
WO1998043643A1 (fr) * | 1997-04-01 | 1998-10-08 | Toa Medicine Co., Ltd. | Preparations d'une solution aqueuse d'acyclovir |
-
1997
- 1997-09-03 GB GBGB9718568.0A patent/GB9718568D0/en active Pending
-
1998
- 1998-09-02 GB GB9818973A patent/GB2328872B/en not_active Expired - Fee Related
- 1998-09-02 ES ES98940460T patent/ES2186207T3/es not_active Expired - Lifetime
- 1998-09-02 DE DE69808938T patent/DE69808938T2/de not_active Expired - Fee Related
- 1998-09-02 WO PCT/GB1998/002637 patent/WO1999011239A1/en active IP Right Grant
- 1998-09-02 CA CA002301325A patent/CA2301325A1/en not_active Abandoned
- 1998-09-02 EP EP98940460A patent/EP1009380B1/de not_active Expired - Lifetime
- 1998-09-02 US US09/145,900 patent/US6379692B1/en not_active Expired - Fee Related
- 1998-09-02 AT AT98940460T patent/ATE226428T1/de not_active IP Right Cessation
- 1998-09-02 AU AU88782/98A patent/AU741609B2/en not_active Ceased
- 1998-09-02 DK DK98940460T patent/DK1009380T3/da active
- 1998-09-03 JP JP10265712A patent/JPH11228386A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
GB9718568D0 (en) | 1997-11-05 |
AU741609B2 (en) | 2001-12-06 |
CA2301325A1 (en) | 1999-03-11 |
GB2328872B (en) | 2002-04-03 |
DK1009380T3 (da) | 2003-02-24 |
EP1009380B1 (de) | 2002-10-23 |
JPH11228386A (ja) | 1999-08-24 |
DE69808938T2 (de) | 2003-07-03 |
WO1999011239A1 (en) | 1999-03-11 |
ATE226428T1 (de) | 2002-11-15 |
US6379692B1 (en) | 2002-04-30 |
GB2328872A (en) | 1999-03-10 |
ES2186207T3 (es) | 2003-05-01 |
GB9818973D0 (en) | 1998-10-21 |
AU8878298A (en) | 1999-03-22 |
EP1009380A1 (de) | 2000-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
EP1077070A3 (de) | Orale Darreichungsform | |
DE69531741D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
FI950319A (fi) | Säädellyn vapautumisnopeuden omaava morfiinivalmiste | |
ATE544447T1 (de) | Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung | |
GB9400981D0 (en) | Preparation of microparticles | |
EA200001125A1 (ru) | Гелеобразные фармацевтические композиции | |
DE69931159D1 (de) | Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat | |
DE69808938D1 (de) | Verfahren zur herstellung von pharmazeutischen zusammensetzungen | |
ATE311373T1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
DE336200T1 (de) | Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung. | |
CA2284774A1 (en) | Theobromine antitussive compositions | |
BR9809492A (pt) | Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma | |
DE69922017D1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
ATE110723T1 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
ATE126052T1 (de) | System zur gesteuerten freisetzung von wirkstoffen sowie verfahren zu dessen herstellung. | |
KR910015297A (ko) | 오메프라졸 경구용 약제와 그 제조방법 | |
ATE12649T1 (de) | Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate. | |
IE61287B1 (en) | Pharmaceutical composition for the transdermal application of herparin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |